Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record.

Comprehensive review on additives of topical dosage forms for drug delivery

Open access
Garg, Tarun, Rath, Goutam, Goyal, Amit K. · 2015 · Drug Delivery

Abstract

Skin is the largest organ of the human body and plays the most important role in protecting against pathogen and foreign matter. Three important modes such as topical, regional and transdermal are widely used for delivery of various dosage forms. Among these modes, the topical dosage forms are preferred because it provides local therapeutic activity when applied to the skin or mucous membranes. Additives or pharmaceutical excipients (non-drug component of dosage form) are used as inactive ingredients in dosage form or tools for structuring dosage forms. The main use of topical dosage form additives are controling the extent of absorption, maintaining the viscosity, improving the stability as well as organoleptic property and increasing the bulk of the formulation. The overall goal of this article is to provide the clinician with information related to the topical dosage form additives and their current major applications against various diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/10717544.2013.879355

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 195

  1. 10.1016/j.ejpb.2012.06.006 · doi:10.1016/j.ejpb.2012.06.006
  2. 10.4137/OED.S3612 · doi:10.4137/oed.s3612
  3. 10.1166/jbn.2013.1569 · DOI
  4. 10.1016/j.ijpharm.2010.09.007 · doi:10.1016/j.ijpharm.2010.09.007
  5. 10.3109/10837450.2010.495394 · doi:10.3109/10837450.2010.495394
  6. 10.1208/s12248-008-9024-9 · DOI · Paper page
  7. 10.1111/j.1468-2494.2010.00633.x · DOI
  8. 10.1002/jps.22183 · DOI
  9. 10.1021/bm400898t · doi:10.1021/bm400898t
  10. 10.1046/j.1365-2133.2003.04950.x · doi:10.1046/j.1365-2133.2003.04950.x
  11. 10.1016/j.ijpharm.2012.07.074 · doi:10.1016/j.ijpharm.2012.07.074
  12. Asakawa M, 1989, Hinyokika Kiyo, 35, 39
  13. 10.4014/jmb.1202.02013 · doi:10.4014/jmb.1202.02013
  14. 10.1208/s12249-011-9661-7 · DOI
  15. 10.1016/j.mehy.2013.09.027 · DOI
  16. 10.1016/j.actatropica.2012.06.004 · DOI
  17. Belov SV, 2013, Med Tekh, 2, 20
  18. 10.3109/10837450.2013.763260 · DOI
  19. 10.4103/2230-973X.114896 · doi:10.4103/2230-973x.114896
  20. 10.1016/j.biomaterials.2013.09.073 · DOI
  21. Bikkad ML, 2013, J Liposome Res
  22. Birkenfeld B, 2011, Pol J Vet Sci, 14, 621, 10.2478/v10181-011-0092-x · doi:10.2478/v10181-011-0092-x
  23. 10.1016/j.oooo.2012.07.487 · DOI
  24. 10.1615/JEnvironPatholToxicolOncol.v26.i4.60 · doi:10.1615/jenvironpatholtoxicoloncol.v26.i4.60
  25. 10.1007/s00403-011-1130-3 · DOI
  26. 10.1016/S0005-2736(01)00369-8 · DOI · Paper page
  27. 10.1016/j.bbamem.2004.01.006 · DOI · Paper page
  28. 10.1177/096032719601500905 · doi:10.1177/096032719601500905
  29. 10.2166/wst.2013.013 · doi:10.2166/wst.2013.013
  30. 10.1016/j.jcis.2013.01.065 · DOI
  31. 10.1021/jp9006763 · DOI
  32. 10.1109/TBCAS.2009.2021769 · DOI
  33. 10.1016/j.actbio.2013.07.002 · DOI
  34. 10.1088/1758-5082/2/3/035004 · DOI · Paper page
  35. 10.1093/rheumatology/ket133 · DOI
  36. 10.1016/S0168-3659(03)00014-2 · doi:10.1016/s0168-3659(03)00014-2
  37. 10.1016/j.bbagen.2013.06.001 · doi:10.1016/j.bbagen.2013.06.001
  38. 10.1159/000018281 · doi:10.1159/000018281
  39. 10.1039/c3cc42596g · doi:10.1039/c3cc42596g
  40. Derry S, 2013, Cochrane Database Syst Rev, 2, CD007393
  41. 10.1016/j.ijpharm.2011.03.057 · DOI
  42. 10.1098/rsfs.2012.0090 · DOI
  43. 10.1016/j.jpedsurg.2011.08.014 · doi:10.1016/j.jpedsurg.2011.08.014
  44. 10.3109/10717544.2013.843610 · DOI
  45. 10.1016/j.exppara.2006.12.004 · DOI
  46. 10.1007/BF02849891 · DOI
  47. 10.1167/iovs.12-10717 · doi:10.1167/iovs.12-10717
  48. 10.1046/j.1365-2133.2002.04800.x · DOI
  49. 10.1213/ANE.0b013e3181cde5a5 · DOI
  50. 10.1016/j.ijbiomac.2013.03.008 · doi:10.1016/j.ijbiomac.2013.03.008
  51. 10.1097/00042737-199812000-00007 · doi:10.1097/00042737-199812000-00007
  52. 10.2165/11311020-000000000-00000 · doi:10.2165/11311020-000000000-00000
  53. 10.1111/j.1600-0536.2012.02161.x · doi:10.1111/j.1600-0536.2012.02161.x
  54. 10.1111/j.1439-0507.2012.02202.x · DOI
  55. 10.1016/j.ijpharm.2013.06.009 · DOI
  56. 10.1046/j.1365-4362.1999.00782.x · DOI
  57. 10.1371/journal.pone.0074404 · DOI
  58. 10.4103/0378-6323.62961 · doi:10.4103/0378-6323.62961
  59. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.10 · DOI · Paper page
  60. 10.1615/CritRevTherDrugCarrierSyst.2013007259 · DOI
  61. 10.1140/epje/i2013-13030-3 · doi:10.1140/epje/i2013-13030-3
  62. 10.1208/s12249-013-0017-3 · DOI
  63. 10.1016/j.joen.2011.09.020 · DOI
  64. 10.3109/07388551.2012.672319 · doi:10.3109/07388551.2012.672319
  65. Gratieri T, 2013, Eur J Pharm Biopharm
  66. 10.1002/jps.21157 · DOI
  67. Gupta VD, 2012, Int J Pharm Compd, 16, 80
  68. 10.3109/03639045.2010.550299 · doi:10.3109/03639045.2010.550299
  69. 10.1080/09546630802513693 · doi:10.1080/09546630802513693
  70. Herzog J L, 2011, J Drugs Dermatol, 10, 853
  71. 10.1248/bpb.29.705 · DOI
  72. 10.1016/j.biortech.2011.06.049 · DOI
  73. 10.1016/j.ijsu.2013.06.842 · doi:10.1016/j.ijsu.2013.06.842
  74. 10.1248/cpb.58.611 · doi:10.1248/cpb.58.611
  75. 10.1023/A:1011911302005 · DOI
  76. Hussain Shah SN, 2013, Bioimpacts, 3, 11
  77. Iena Ia M, 1993, Lik Sprava, 2, 142
  78. Jain A, 2010, PDA J Pharm Sci Technol, 64, 517
  79. 10.1016/j.ijpharm.2013.05.032 · doi:10.1016/j.ijpharm.2013.05.032
  80. 10.3358/shokueishi.47.167 · doi:10.3358/shokueishi.47.167
  81. 10.1177/1091581811406987 · DOI
  82. 10.1007/s12272-012-0710-x · doi:10.1007/s12272-012-0710-x
  83. 10.1016/j.burns.2011.03.017 · DOI
  84. 10.3168/jds.2012-5942 · doi:10.3168/jds.2012-5942
  85. Khlamova OG, 2011, Antibiot Khimioter, 56, 34
  86. Khozeimeh F, 2010, J Contemp Dent Pract, 11, 017, 10.5005/jcdp-11-2-17 · DOI
  87. 10.1111/j.1365-2133.2009.09477.x · DOI
  88. Kircik L, 2010, J Drugs Dermatol, 9, 137
  89. 10.1128/JCM.01425-08 · DOI
  90. 10.1002/ptr.3509 · doi:10.1002/ptr.3509
  91. 10.1248/cpb.56.1384 · doi:10.1248/cpb.56.1384
  92. 10.3109/02713683.2010.542866 · doi:10.3109/02713683.2010.542866
  93. Lazareva EB, 2002, Antibiot Khimioter, 47, 9
  94. 10.1111/j.1365-2133.2009.09145.x · DOI
  95. 10.1016/j.ejpb.2012.05.011 · DOI
  96. 10.1159/000339652 · doi:10.1159/000339652
  97. 10.1002/cmdc.201200229 · DOI
  98. 10.1016/j.carbpol.2012.07.036 · DOI
  99. 10.1021/mp200558a · DOI
  100. 10.1111/nyas.12214 · DOI
  101. 10.3109/03639045.2012.691510 · DOI
  102. 10.3171/2013.6.SPINE1311 · doi:10.3171/2013.6.spine1311
  103. 10.3390/molecules16064672 · doi:10.3390/molecules16064672
  104. 10.1016/j.ijpharm.2013.06.081 · doi:10.1016/j.ijpharm.2013.06.081
  105. Menter A, 2008, Cutis, 81, 509
  106. 10.1111/j.1473-2165.2008.00405.x · DOI
  107. 10.3748/wjg.v18.i33.4563 · DOI
  108. 10.1016/S0944-7113(00)80084-7 · doi:10.1016/s0944-7113(00)80084-7
  109. 10.1016/j.ijpharm.2011.05.008 · DOI · Paper page
  110. 10.1016/j.colsurfb.2011.05.050 · DOI
  111. 10.1002/jbm.a.34702 · DOI
  112. 10.1007/s10856-012-4740-1 · doi:10.1007/s10856-012-4740-1
  113. 10.1016/S2221-1691(12)60096-3 · DOI
  114. 10.1097/SCS.0b013e3181f43f43 · DOI
  115. Naganathan S, 2010, Waste Manag Res, 28, 848, 10.1177/0734242X09355073 · doi:10.1177/0734242x09355073
  116. 10.1002/bdd.1866 · DOI
  117. 10.1002/jbm.b.31757 · doi:10.1002/jbm.b.31757
  118. 10.2165/11539780-000000000-00000 · doi:10.2165/11539780-000000000-00000
  119. 10.1016/j.ijbiomac.2012.12.008 · DOI · Paper page
  120. 10.1016/j.ijpharm.2011.07.034 · doi:10.1016/j.ijpharm.2011.07.034
  121. 10.1016/j.niox.2012.01.007 · DOI
  122. 10.2147/IJN.S40519 · DOI
  123. 10.1016/j.farmac.2004.04.006 · doi:10.1016/j.farmac.2004.04.006
  124. 10.1111/j.2041-1626.2012.00147.x · doi:10.1111/j.2041-1626.2012.00147.x
  125. 10.1067/mjd.2003.174 · DOI
  126. 10.1016/j.biortech.2013.02.061 · DOI
  127. 10.1111/jphp.12093 · DOI
  128. 10.1021/am400546x · doi:10.1021/am400546x
  129. Parnami N, 2013, Artif Cells Nanomed Biotechnol
  130. 10.1016/j.bpc.2010.03.015 · DOI
  131. 10.1080/09546630410023566 · doi:10.1080/09546630410023566
  132. 10.1016/j.ijpharm.2012.04.051 · DOI
  133. 10.1016/j.ejpb.2012.11.026 · DOI
  134. Puri R, 2012, Anticancer Drugs, 23, 923, 10.1097/CAD.0b013e3283534051 · doi:10.1097/cad.0b013e3283534051
  135. 10.1016/S1673-8527(07)60102-7 · DOI
  136. 10.1185/03007990802381364 · DOI
  137. 10.1007/s10928-006-9019-z · doi:10.1007/s10928-006-9019-z
  138. Rhoades J, 2013, J Appl Microbiol, 115, 987, 10.1111/jam.12302 · doi:10.1111/jam.12302
  139. Romantsov MG, 2009, Antibiot Khimioter, 54, 52
  140. 10.1111/j.1743-6109.2008.01118.x · DOI
  141. 10.4103/2230-973X.104397 · doi:10.4103/2230-973x.104397
  142. 10.1016/j.ejpb.2012.12.010 · DOI
  143. 10.3109/10837450.2013.819012 · doi:10.3109/10837450.2013.819012
  144. 10.1007/s00394-009-0042-x · DOI
  145. Sankar V, 2009, Pharmazie, 64, 731
  146. 10.1021/jp804176v · doi:10.1021/jp804176v
  147. 10.1093/bja/aen364 · DOI
  148. 10.1080/09593332508618434 · doi:10.1080/09593332508618434
  149. 10.1016/j.ijpharm.2010.10.036 · doi:10.1016/j.ijpharm.2010.10.036
  150. 10.1016/j.ijbiomac.2013.06.049 · doi:10.1016/j.ijbiomac.2013.06.049
  151. Shalonov PM, 1989, Klin Khir, 3, 53
  152. Shalviri A, 2011, J Pharm Pharm Sci, 14, 315, 10.18433/J38P4V · doi:10.18433/j38p4v
  153. Shatalov VN, 1988, Farmakol Toksikol, 51, 60
  154. 10.1248/yakushi.13-00004 · DOI
  155. 10.4103/2230-973X.107002 · doi:10.4103/2230-973x.107002
  156. 10.1208/s12249-009-9242-1 · doi:10.1208/s12249-009-9242-1
  157. Shul'diakov AA, 2012, Klin Med (Mosk), 90, 61
  158. Shul'diakov AA, 2012, Eksp Klin Farmakol, 75, 35
  159. 10.4155/tde.11.152 · doi:10.4155/tde.11.152
  160. 10.1073/pnas.1311355110 · DOI
  161. Soboleva LA, 2011, Eksp Klin Farmakol, 74, 41
  162. 10.1016/j.ctim.2012.05.001 · DOI
  163. 10.1016/j.saa.2012.05.088 · doi:10.1016/j.saa.2012.05.088
  164. Spraker MK, 2006, Cutis, 77, 113
  165. 10.1016/j.jaad.2005.04.029 · DOI
  166. 10.1016/S0966-6532(01)00077-4 · doi:10.1016/s0966-6532(01)00077-4
  167. Stough D, 2008, J Clin Aesthet Dermatol, 1, 16
  168. 10.1158/1940-6207.CAPR-09-0183 · doi:10.1158/1940-6207.capr-09-0183
  169. 10.1016/j.talanta.2006.07.046 · doi:10.1016/j.talanta.2006.07.046
  170. 10.1046/j.1365-2133.2001.04467.x · doi:10.1046/j.1365-2133.2001.04467.x
  171. 10.5021/ad.2013.25.1.5 · doi:10.5021/ad.2013.25.1.5
  172. 10.1111/j.1600-0846.2011.00600.x · doi:10.1111/j.1600-0846.2011.00600.x
  173. 10.3109/2000656X.2012.717897 · doi:10.3109/2000656x.2012.717897
  174. 10.1016/j.ejps.2012.12.014 · DOI
  175. 10.1016/j.ejps.2013.03.013 · DOI · Paper page
  176. 10.1016/j.nano.2012.05.008 · DOI
  177. 10.1159/000211405 · DOI
  178. 10.1208/s12249-012-9914-0 · DOI
  179. 10.4103/0975-1483.93570 · DOI
  180. 10.1016/j.actbio.2013.08.009 · doi:10.1016/j.actbio.2013.08.009
  181. 10.3748/wjg.v11.i45.7208 · doi:10.3748/wjg.v11.i45.7208
  182. 10.1080/09205063.2013.789357 · DOI
  183. 10.1615/CritRevTherDrugCarrierSyst.2013007362 · DOI
  184. 10.1016/j.ijpharm.2010.03.029 · DOI
  185. 10.1016/S0304-3940(03)00511-1 · DOI
  186. 10.1159/000029903 · doi:10.1159/000029903
  187. Wikiera A, 2013, Postepy Biochem, 59, 89
  188. 10.1002/jps.23548 · doi:10.1002/jps.23548
  189. 10.1016/S0168-3659(97)00143-0 · doi:10.1016/s0168-3659(97)00143-0
  190. 10.1166/jbn.2013.1555 · DOI
  191. Zhang YT, 2011, Int J Nanomedicine, 6, 2469
  192. 10.1016/j.msec.2013.06.034 · doi:10.1016/j.msec.2013.06.034
  193. 10.1002/jsfa.6146 · DOI
  194. Zivkovich AH, 2009, J Drugs Dermatol, 8, 570
  195. 10.1007/s00011-009-0065-z · DOI

Cited by

See all 161

Metadata

Authors
Garg, T., Rath, G., & Goyal, A. K.
Venue
Drug Delivery
Published
2014-01-23
Volume
22
Issue
8
Pages
969-987
ISSN
  • 1071-7544 (ISSN-L)
  • 1521-0464
OpenAlex
W1966914419
Cited by
161
References
0
FWCI
5.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive review on additives of topical dosage forms for drug delivery. https://app.cochat.ai/papers/10.3109/10717544.2013.879355
The paper
Garg, T., Rath, G., & Goyal, A. K. (2015). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Delivery. https://doi.org/10.3109/10717544.2013.879355

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.